BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 27678362)

  • 21. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
    J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined positron emission tomography/computed tomography for diagnosis and monitoring of orbital adnexal lymphoma.
    Klingenstein A; Garip-Kuebler A; Mueller-Lisse UG; Hintschich C
    Acta Ophthalmol; 2018 Sep; 96(6):e712-e717. PubMed ID: 30146694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
    Lim SM; Kim H; Kang B; Kim HS; Rha SY; Noh SH; Hyung WJ; Cheong JH; Kim HI; Chung HC; Yun M; Cho A; Jung M
    Ann Nucl Med; 2016 May; 30(4):279-86. PubMed ID: 26837515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation.
    Park YJ; Hyun SH; Moon SH; Lee KH; Min BH; Lee JH; Kim WS; Kim SJ; Choi JY
    Sci Rep; 2021 Apr; 11(1):9243. PubMed ID: 33927319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
    Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
    Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The value of (18)F-FDG PET-CT imaging in predicting the malignant potential of GIST].
    Li SX; Tang MD; Lin DY; Liu DJ; Lyu QH; Zhang JP; Cai ZH
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):821-827. PubMed ID: 29151288
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical significance of
    Zhang Y; Han J; Li J; Cao J; Zhou Y; Deng S; Zhang B; Yang Y
    J Cancer Res Clin Oncol; 2024 May; 150(5):265. PubMed ID: 38769201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18F-FDG PET/CT in splenic marginal zone lymphoma.
    Albano D; Giubbini R; Bertagna F
    Abdom Radiol (NY); 2018 Oct; 43(10):2721-2727. PubMed ID: 29500652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Positron Emission Tomography/Computed Tomography in Gastric Mucosa-associated Lymphoid Tissue Lymphoma.
    Hwang JW; Jee SR; Lee SH; Kim JH; Seol SY; Lee SM
    Korean J Gastroenterol; 2016 Apr; 67(4):183-8. PubMed ID: 27112244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of ¹⁸F-FDG PET/CT and large-scale DWI for evaluation of non-Hodgkin lymphoma bone marrow infiltration].
    Tang R; Gui S; Li J; Zhang H; Lu B; Yang P; Fu D; Fu W; Li W; Cai L
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):231-5. PubMed ID: 24666490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SUVmax of 18F-FDG PET/CT correlates to expression of major chemotherapy-related tumor markers and serum tumor markers in gastric adenocarcinoma patients.
    Bai L; Guo CH; Zhao Y; Gao JG; Li M; Shen C; Guo YM; Duan XY
    Oncol Rep; 2017 Jun; 37(6):3433-3440. PubMed ID: 28498457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Importance of Bone Marrow Uptake on Baseline
    Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Value of Restaging F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict 3-Year Post-Recurrence Survival in Patients with Recurrent Gastric Cancer after Curative Resection.
    Kim SH; Song BI; Kim HW; Won KS; Son YG; Ryu SW
    Korean J Radiol; 2020 Jul; 21(7):829-837. PubMed ID: 32524783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidental focal colorectal ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography.
    Cho SH; Kim SW; Kim WC; Park JM; Yoo IeR; Kim SH; Oh ST
    World J Gastroenterol; 2013 Jun; 19(22):3453-8. PubMed ID: 23801838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of metabolic response with
    Segreto S; Fonti R; Ottaviano M; Pellegrino S; Pace L; Damiano V; Palmieri G; Del Vecchio S
    Cancer Imaging; 2017 Mar; 17(1):10. PubMed ID: 28264726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation Between Infection Status of Epstein-Barr Virus and
    Na SJ; Park HL; O JH; Lee SY; Song KY; Kim SH
    In Vivo; 2017; 31(4):749-753. PubMed ID: 28652452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does dual-time-point
    Wu B; Zhao Y; Zhang Y; Tan H; Shi H
    Hell J Nucl Med; 2017; 20(1):79-82. PubMed ID: 28315913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic role of 18F-FDG PET in gastric MALT lymphoma.
    Ambrosini V; Rubello D; Castellucci P; Nanni C; Farsad M; Zinzani P; Alavi A; Tehranipour N; Al-Nahhas A; Fanti S
    Nucl Med Rev Cent East Eur; 2006; 9(1):37-40. PubMed ID: 16791802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.